<DOC>
	<DOCNO>NCT00337922</DOCNO>
	<brief_summary>This study design explore drug level blood Japanese HIV-infected patient take EPZICOM tablet least 2 week prior administration study drug . Pharmacokinetics administration EPZICOM tablet investigate total 8 subject .</brief_summary>
	<brief_title>Pharmacokinetic Study Of EPZICOM Tablet</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Dideoxynucleosides</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Inclusion criterion : A Japanese HIVinfected patient continue use one EPZICOM tablet morning ( 00:00 12:00 ) least 2 week prior administration study drug . A patient agree abstain alcohol 48 hour prior administration study drug completion blood sample pharmacokinetic analysis . Exclusion criterion : A patient develop AIDS ( Patients develop AIDS past symptom finding may serve indicator screen may eligible study . ) A patient history hypersensitivity study drug ingredient ( lamivudine , abacavir sulfate ) study drug</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>EPZICOM</keyword>
	<keyword>Lamivudine</keyword>
	<keyword>Abacavir</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>Japanese</keyword>
</DOC>